Patents by Inventor Jean-Hilaire Saurat

Jean-Hilaire Saurat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190175677
    Abstract: The present invention relates to a Silybum marianum (L.) Gaertn. extract comprising less than 0.2% by weight of silymarin with respect to the weight of the dry extract, as well as pharmaceutical and cosmetic compositions containing same, the preparation method thereof and uses thereof as a medicinal product, particularly in the treatment of acne, seborrhoea, seborrheic dermatitis and/or rosacea.
    Type: Application
    Filed: June 30, 2017
    Publication date: June 13, 2019
    Applicant: PIERRE FABRE DERMO-COSMETIQUE
    Inventors: Jean-Hilaire SAURAT, Olivier SORG, Mathieu LETI, Bernard FABRE
  • Patent number: 10213375
    Abstract: The invention concerns topical compositions based on retinaldehyde, glycylglycine oleamide and, if necessary, delta-tocopheryl-glucopyranoside, and their use in cosmetology and dermatology to combat skin ageing and more particularly light-induced skin ageing.
    Type: Grant
    Filed: June 3, 2014
    Date of Patent: February 26, 2019
    Assignee: PIERRE FABRE DERMO-COSMETIQUE
    Inventors: Daniel Bacqueville, Patrick Bogdanowicz, Jean-Hilaire Saurat, Olivier Sorg
  • Patent number: 10188625
    Abstract: The present invention concerns a combination of a retinoid and a diol and polyunsaturated fatty acid ester, a dermatological or dermocosmetic composition containing such a combination and use of same in the treatment of acne and the prevention of retentional lesions. The present invention also concerns a retinoid, optionally in combination with a diol and polyunsaturated fatty acid ester, for use in the prevention of retentional lesions.
    Type: Grant
    Filed: February 29, 2016
    Date of Patent: January 29, 2019
    Assignee: PIERRE FABRE DERMO-COSMETIQUE
    Inventors: Nathalie Castex-Rizzi, Daniel Redoules, Sandrine Bessou-Touya, Jean-Hilaire Saurat
  • Publication number: 20180185325
    Abstract: The present invention provides compounds of the following structure, methods of using such compounds, and pharmaceutical compositions containing such compounds. In addition, this invention provides methods for the treatment and/or prevention of disease states mediated by Aryl Hydrocarbon receptor pathways.
    Type: Application
    Filed: June 8, 2016
    Publication date: July 5, 2018
    Applicant: Thesan Pharmaceuticals, Inc.
    Inventors: Nigel Robert Arnold Beeley, Howard Glenn Welgus, Jay Edward Birnbaum, J. Gordon Foulkes, Celia Patricia Jenkinson, Jean Hilaire Saurat
  • Publication number: 20180179174
    Abstract: The present invention provides compounds of the following structure, methods of using such compounds, and pharmaceutical compositions containing such compounds. In addition, this invention provides methods for the treatment and/or prevention of disease states mediated by Aryl Hydrocarbon receptor pathways.
    Type: Application
    Filed: June 6, 2016
    Publication date: June 28, 2018
    Applicant: Thesan Pharmaceuticals, Inc.
    Inventors: Nigel Robert Arnold Beeley, Howard Glenn Welgus, Jay Edward Birnbaum, J. Gordon Foulkes, Celia Patricia Jenkinson, Jean Hilaire Saurat
  • Patent number: 9993417
    Abstract: The present invention relates to a combination comprising a hyaluronic acid or a salt thereof and a sulphated polysaccharide of which the molecular weight is between 5 and 25 kDa, which is of use in particular for combating the signs of skin ageing or for treating and healing skin wounds.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: June 12, 2018
    Assignee: PIERRE FABRE DERMO-COSMETIQUE
    Inventors: Stéphane Poigny, Hélène Hernandez-Pigeon, Jean-Hilaire Saurat, Gürkan Kaya
  • Publication number: 20180118707
    Abstract: The present invention provides compounds of the following structure, methods of using such compounds, and pharmaceutical compositions containing such compounds. In addition, this invention provides methods for the treatment and/or prevention of disease states mediated by Aryl Hydrocarbon receptor pathways.
    Type: Application
    Filed: June 7, 2016
    Publication date: May 3, 2018
    Applicant: Thesan Pharmaceuticals, Inc.
    Inventors: Nigel Robert Arnold Beeley, Howard Glenn Welgus, Jay Edward Birnbaum, J. Gordon Foulkes, Celia Patricia Jenkinson, Jean Hilaire Saurat
  • Publication number: 20180036275
    Abstract: The present invention concerns a combination of a retinoid and a diol and polyunsaturated fatty acid ester, a dermatological or dermocosmetic composition containing such a combination and use of same in the treatment of acne and the prevention of retentional lesions. The present invention also concerns a retinoid, optionally in combination with a diol and polyunsaturated fatty acid ester, for use in the prevention of retentional lesions.
    Type: Application
    Filed: February 29, 2016
    Publication date: February 8, 2018
    Applicant: PIERRE FABRE DERMO-COSMETIQUE
    Inventors: Nathalie CASTEX-RIZZI, Daniel REDOULES, Sandrine BESSOU-TOUYA, Jean-Hilaire SAURAT
  • Publication number: 20170049678
    Abstract: The present invention relates to a combination comprising a hyaluronic acid or a salt thereof and a sulphated polysaccharide of which the molecular weight is between 5 and 25 kDa, which is of use in particular for combating the signs of skin ageing or for treating and healing skin wounds.
    Type: Application
    Filed: April 30, 2015
    Publication date: February 23, 2017
    Applicant: PIERRE FABRE DERMO-COSMETIQUE
    Inventors: Stéphane POIGNY, Hélène HERNANDEZ-PIGEON, Jean-Hilaire SAURAT, Gürkan KAYA
  • Publication number: 20170042856
    Abstract: The subject invention provides a method of treating acne in a subject which comprises topically and periodically applying to the subject's acne a composition comprising 3-phenyl-benzo[f]chromen-1-one and a pharmaceutically acceptable carrier, wherein the 3-phenyl-1-benzo[f]chromen-1-one is present in an amount effective to treat the subject's acne. The subject invention also provides a method of treating a skin condition associated with abnormal sebum secretion or abnormal sebaceous gland function in a subject, compositions in such methods and a sorting method for identifying agonists of AhR pathway useful in such methods and compositions.
    Type: Application
    Filed: October 26, 2016
    Publication date: February 16, 2017
    Applicant: Thesan Pharmaceuticals, Inc.
    Inventor: Jean Hilaire Saurat
  • Patent number: 9480674
    Abstract: The subject invention provides a method of treating acne in a subject which comprises topically and periodically applying to the subject's acne a composition comprising 3-phenyl-1-benzo[f]chromen-1-one and a pharmaceutically acceptable carrier, wherein the 3-phenyl-1-benzo[f]chromen-1-one is present in an amount effective to treat the subject's acne. The subject invention also provides a method of treating a skin condition associated with abnormal sebum secretion or abnormal sebaceous gland function in a subject, compositions in such methods and a sorting method for identifying agonists of AhR pathway, useful in such methods and compositions.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: November 1, 2016
    Assignee: THESAN PHARMACEUTICALS, INC.
    Inventor: Jean Hilaire Saurat
  • Patent number: 9463182
    Abstract: The use, as a dermatological or cosmetic ingredient, of compounds capable of transiently interacting with the AhR receptor (aryl hydrocarbon receptor) as agents for modulating skin functions such as sebaceous function, skin healing, skin atrophy termed “dermatoporosis”, estrogen deprivation and defense against infection, without inducing other toxic effects of the TCDD type. The compounds that interact the AhR receptor are chosen in that they have a metabolism favorable to the dissociation of these effects, in particular by virtue of in situ production from a precursor and/or metabolization in situ.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: October 11, 2016
    Assignee: THESAN PHARMACEUTICALS, INC.
    Inventor: Jean Hilaire Saurat
  • Publication number: 20160206542
    Abstract: The invention concerns topical compositions based on retinaldehyde, glycylglycine oleamide and, if necessary, delta-tocopheryl-glucopyranoside, and their use in cosmetology and dermatology to combat skin ageing and more particularly light-induced skin ageing.
    Type: Application
    Filed: June 3, 2014
    Publication date: July 21, 2016
    Applicant: PIERRE FABRE DERMO-COSMETIQUE
    Inventors: Daniel BACQUEVILLE, Patrick BOGDANOWICZ, Jean-Hilaire SAURAT, Olivier SORG
  • Patent number: 9358220
    Abstract: The use, as a dermatological or cosmetic medicament, of compounds capable of transiently interacting with the AhR receptor (aryl hydrocarbon receptor) as agents for modulating skin functions such as sebaceous function, skin healing, skin atrophy termed “dermatoporosis”, estrogen deprivation and defense against infection, without inducing other toxic effects of the TCDD type. The compounds that interact with the AhR receptor are chosen in that they have a metabolism favorable to the dissociation of these effects, in particular by virtue of in situ production from a precursor and/or metabolization modulated in situ.
    Type: Grant
    Filed: January 28, 2015
    Date of Patent: June 7, 2016
    Assignee: THESAN PHARMACEUTICALS, INC.
    Inventor: Jean Hilaire Saurat
  • Publication number: 20150216840
    Abstract: The use, as a dermatological or cosmetic medicament, of compounds capable of transiently interacting with the AhR receptor (aryl hydrocarbon receptor) as agents for modulating skin functions such as sebaceous function, skin healing, skin atrophy termed “dermatoporosis”, estrogen deprivation and defense against infection, without inducing other toxic effects of the TCDD type. The compounds that interact with the AhR receptor are chosen in that they have a metabolism favorable to the dissociation of these effects, in particular by virtue of in situ production from a precursor and/or metabolization modulated in situ.
    Type: Application
    Filed: January 28, 2015
    Publication date: August 6, 2015
    Inventor: Jean Hilaire Saurat
  • Patent number: 9011885
    Abstract: The use, as a dermatological or cosmetic medicament, of compounds capable of transiently interacting with the AhR receptor (aryl hydrocarbon receptor) as agents for modulating skin functions such as sebaceous function, skin healing, skin atrophy termed “dermatoporosis”, estrogen deprivation and defense against infection, without inducing other toxic effects of the TCDD type. The compounds that interact with the AhR receptor are chosen in that they have a metabolism favorable to the dissociation of these effects, in particular by virtue of in situ production from a precursor and/or metabolization modulated in situ.
    Type: Grant
    Filed: July 30, 2014
    Date of Patent: April 21, 2015
    Assignee: Thesan Pharmaceuticals, Inc.
    Inventor: Jean Hilaire Saurat
  • Publication number: 20150094351
    Abstract: The use, as a dermatological or cosmetic medicament, of compounds capable of transiently interacting with the AhR receptor (aryl hydrocarbon receptor) as agents for modulating skin functions such as sebaceous function, skin healing, skin atropy termed “dermatoporosis”, estrogen deprivation and defense against infection, without inducing other toxic effects of the TCDD type. The compounds that interact with the AhR receptor are chosen in that they have a metabolism favorable to the dissociation of these effects, in particular by virtue of in situ production from a precursor and/or metabolization modulated in situ.
    Type: Application
    Filed: November 7, 2014
    Publication date: April 2, 2015
    Applicant: THESAN PHARMACEUTICALS, INC.
    Inventor: Jean Hilaire SAURAT
  • Patent number: 8968751
    Abstract: The inventive compositions for topical application are characterized in that they comprises one or several hyaluronate fragments in the form of a main principle whose molecular weight ranges from 50 000 and 750 000 Da and a retinoid if necessary.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: March 3, 2015
    Assignee: Pierre Fabre Dermo Cosmetique
    Inventors: Jean-Hilaire Saurat, Gürkan Kaya, Pascal Bordat
  • Publication number: 20150057343
    Abstract: The subject invention provides a method of treating acne in a subject which comprises topically and periodically applying to the subject's acne a composition comprising 3-phenyl-1-benzo[f]chromen-1-one and a pharmaceutically acceptable carrier, wherein the 3-phenyl-1-benzo[f]chromen-1-one is present in an amount effective to treat the subject's acne. The subject invention also provides a method of treating a skin condition associated with abnormal sebum secretion or abnormal sebaceous gland function in a subject, compositions in such methods and a sorting method for identifying agonists of AhR pathway, useful in such methods and compositions.
    Type: Application
    Filed: November 7, 2014
    Publication date: February 26, 2015
    Applicant: THESAN PHARMACEUTICALS, INC.
    Inventor: Jean Hilaire SAURAT
  • Patent number: 8961944
    Abstract: The present invention relates to a cosmetic or pharmaceutical composition for cutaneous application, whose goal is the depigmentation of the skin.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: February 24, 2015
    Assignee: Pierre Fabre Dermo-Cosmetique
    Inventors: Stéphane Poigny, Françoise Belaubre, Jean-Hilaire Saurat, Olivier Sorg, Behrooz Kasraee